[1]吴琼,杨爱玲,周端,等.扩张型心肌病左室逆重构的研究进展[J].心血管病学进展,2019,(6):885-889.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.012]
　WU Qiong,YANG Ailing,ZHOU Duan,et al.Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(6):885-889.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.012]

点击复制

扩张型心肌病左室逆重构的研究进展(/HTML)

分享到：

参考文献/References:

[1]胡奕然.心脏逆重构的研究进展[J].中国循环杂志,2017,32(7):714-716.

[2]?Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failingheart[J].J Am Coll Cardiol,2012,60(24):2465-2472.

[3]MerloM,PivettaA,PinamontiB,et al.Long-term prognostic impact of therapeutic strategies in patients withidiopathic dilated cardiomyopathy:changing mortality over the last 30 years[J].EurJ Heart Fail,2014,16(3):317-324.

[4]MerloM, GobboM, StolfoD, et al.The prognostic impact ofthe evolution of RV function in idiopathic DCM[J].?JACC Cardiovasc?Imaging,2016,9(9):1034-1042.

[5]?Matsumura Y,Hoshikawa-Nagai E,Kubo T,et al.?Left ventricular reverse remodeling in long-term (>12 years)survivors with idiopathic dilated cardiomyopathy[J].Am JCardiol,2013,111(1):106-110.

[6]Merlo M,Stolfo D,Anzini M,et al. Persistent recoveryof normal left ventricular function and dimension in idiopathicdilated cardiomyopathy during long-term followup:does real healing exist??[J].J?Am Heart Assoc,2015,4(14):e001504.

[7]Hoshikawa?E, Matsumura?Y,KuboT, et al.Effect of left ventricular reverse remodeling on long-term prognosisafter therapywith angiotensin-converting enzyme inhibitors or angiotensin II receptorblockers and beta blockers in patients with idiopathic dilated cardiomyopathy?[J].Am J Cardiol,2011,107(7):1065-1070.

[8]AdamoL,PerryA,NovakE,et al.?Abnormal globallongitudinal strain predicts future deterioration of left ventricular function inheart failure patients with a recovered left ventricular ejection fraction[J].Circ HeartFail,2017,10(6):e003788.

[9]Merlo M,Pyxaras SA,Pinamonti B,et al. Prevalence andprognostic significance of left ventricular reverse remodelingin dilated cardiomyopathy receiving tailored medicaltreatment[J].J Am Coll Cardiol,2011,57(13):1468-1476.

[10]王世鹏,徐俊波,胡咏梅,等.?扩张型心肌病研究进展[J].心血管病学进展,2017,38:229-232.

[11]Zecchin?M, Proclemer?A,Magnani?S,et al.?Long-term outcome of “superresponder”patients to cardiac resynchronization therapy[J].?Europace,2014,16(3):363-371.

[12]Jansweijer JA,Nieuwhof K,Russo F,et al. Truncatingtitin mutations are associated with a mild and treatableform of dilated cardiomyopathy[J].?Eur J Heart Fail,2017,19(4):512-521.

[13]Felkin LE,Walsh R,Ware JS,et al. Recovery of cardiacfunction in cardiomyopathy caused by titin truncation[J].JAMA Cardiol,2016,1(2):234-235.

[14]Ponikowski P,?Voors AA,?Anker SD,et al.?2016 ESC guidelines for the diagnosis andtreatment of acute and chronic heart failure[J].?Eur Heart J,2016,37(27):2129-2200.

[15]MannDL,BargerPM,BurkhoffD.Myocardial recovery and the failing heart:myth,magic, or molecular target?[J].J AmCollCardiol,2012,60(24):2465-2472.

[16]中华医学会心血管病学分会,中国心肌炎心肌病协作组.中国扩张型心肌病诊断和治疗指南[J].临床心血管病杂志,2018,34(5):421-434.

[17]Nerheim P, Birger-Botkin S, Piracha L, et al. Heart failureand sudden death in patients with tachycardia-inducedcardiomyopathy and recurrent tachycardia[J].Circulation,2004,110(3):247-252

[18]Mann DL,Barger PM,Burkhoff D. Myocardialrecovery and the failing heart:myth,magic,or moleculartarget?[J].J Am Coll Cardiol,2012,60(24):2465-2472.

[19]Miles C,?Finocchiaro G,?Papadakis M,et al. Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy[J].Circulation,2019,10(3):e037230.

[20]Ewer MS,Vooletich MT,Durand JB,et al. Reversibilityof trastuzumab-related cardiotoxicity: new insights basedon clinical course and response to medical treatment[J].J Clin Oncol,2005,23(31):7820-7826.

[21]McNamara DM,Elkayam U,Alharethi R,et al. Clinicaloutcomes for peripartum cardiomyopathy in NorthAmerica: Results of the IPAC Study(Investigations of Pregnancy-Associated Cardiomyopathy)[J].?J Am CollCardiol,2015,66(8):905-914.

[22]Anzini?M,Merlo?M,Sabbadini?G,et al.?Long-term evolutionand prognostic stratification of biopsy-proven active myocarditis[J].Circulation,2013,128(22):2384-2394.

[23]McNamara DM,Starling RC,Cooper LT,et al. Clinicaland demographic predictors of outcomes in recent onsetdilated cardiomyopathy: Results of the IMAC(Intervention in Myocarditis and AcuteCardiomyopathy)-2 study[J].J Am Coll Cardiol,2011,58(11):1112-1118.

[24]巫雪飞,黄燕,房晓楠,等.扩张型心肌病患者经标准药物治疗后左心室射血分数恢复正常的发生率及预测因素分析[J].中国循环杂志,2015,30(5):417-421.

[25]Ponikowski P,Voors AA,Anker SD,et al. 2016 ESC guidelines for the diagnosis and

treatment of acute and chronic heart failure[J].Eur Heart J,2016,37(27):2129-2200.

[26]Becker MAJ,?Cornel JH,?van de Ven PM,et al.The Prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy[J]. JACC Cardiovasc Imaging,2018,11(9):1274-1284.

[27]Kubanek M,Sramko M,Maluskova J,et al. Novel predictorsof left ventricular reverse remodeling in individualswith recent-onset dilated cardiomyopathy[J].J Am CollCardiol,2013,61(1):54-63.

[28]Leong DP,Chakrabarty A,Shipp N,et al. Effects ofmyocardial fibrosis and ventricular dyssynchronyonresponse to therapy in new-presentation idiopathic dilatedcardiomyopathy:?insights from cardiovascular magneticresonance and echocardiography[J].Eur Heart J,2012,33(5):640-648.

[29]Amorim S,Campelo M,Martins E,et al. Prevalence,predictors and prognosis of ventricular reverse remodelingin idiopathic dilated cardiomyopathy[J].?Rev PortCardiol,2016,35(5):253-260.

[30]Broch K,Murbraech K,Andreassen AK,et al.Contemporary outcome in patients with idiopathicdilated cardiomyopathy[J].AmJCardiol,2015,116(6):952-959.

[31]Hoit BD. The Pythian left atrium:predicting LV reverseremodeling and cardiovascular events in new-onset dilatedcardiomyopathy[J].J Card Fail,2016,22(4):280-282.

[32]Moon J,Shim CY,Kim YJ,et al. Left atrial volume as apredictor of left ventricular functional recovery inpatients with dilated cardiomyopathy and absence ofdelayed enhancement in cardiac magnetic resonance[J].J Card Fail,2016,22(4):265-271.

[33]Ikeda Y,Inomata T,Fujita T,et al. Cardiac fibrosisdetected by magnetic resonance imaging on predictingtime course diversity of left ventricular reverse remodelingin patients with idiopathic dilated cardiomyopathy[J].Heart Vessels,2016,31(11):1817-1825.

[34]Merlo?M, Gobbo?M,Stolfo?D,?et al.?The prognostic impact ofthe evolution of RV function in idiopathic DCM[J].JACC Cardiovasc Imaging,2016,9(9):1034-1042.

[35]Stolfo?D,Merlo?M, Pinamonti?B,?et al.?Early improvement of functional mitral regurgitation in patients withidiopathic dilated cardiomyopathy[J].?Am J Cardiol,2015,115(8):1137-1143

[36]Ahmad?F, SeidmanJG,SeidmanCE.The genetic basis for cardiac remodeling[J].Annu Rev Genomics Hum Genet,2005,6(1):185-216.

[37]Dal Ferro?M, Stolfo?D,Altinier?A,?et al.?Association betweenmutation status and left ventricular reverse remodelling in dilated cardiomyopathy[J].Heart,2017,103(21):1704-1710.

[38]Rossi?A, Dini?FL,Faggiano?P,?et al.?Independent prognosticvalue of functional mitral regurgitation in patients with heart failure. A quantitativeanalysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopath[J].Heart,2011,97(20):1675-1680.

[39]Merlo?M,PyxarasSA,Pinamonti?B,et al.?Prevalenceand prognostic significance ofleft ventricular reverse remodeling in dilated cardiomyopathyreceiving tailored medical treatment[J].J AmColl Cardiol,2011,57(13):1468-1476.

[40]Aleksova?A, Carriere?C, Zecchin?M,?et al.?New-onset left bundle branch block independently predicts long-term mortalityin patients with idiopathic dilated cardiomyopathy:data from the TriesteHeartMuscleDisease Registry[J].?Europace,2014,16(10):1450-1459.

[41]Aleksova?A, Merlo?M,Zecchin?M,?et al.?Impact of atrial fibrillation on outcome of patientswith idiopathic dilatedcardiomyopathy:data from the Heart Muscle Disease Registry of Trieste[J].?Clin MedRes,2010,8(3-4):142-149.

相似文献/References:

[1]张颖雪,赵新湘,孙勇.心脏磁共振成像技术在扩张型心肌病中的应用及研究进展[J].心血管病学进展,2016,(1):74.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.019]
　ZHANG Yingxue,ZHAO Xinxiang,SUN Yong.Application and Research Progress of Cardiac Magnetic Resonance Imaging in Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2016,(6):74.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.019]
[2]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
　LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(6):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[3]梁科研 杨芳 褚静洁.四维超声心动图评价扩张型心肌病右心室整体收缩功能及其临床意义[J].心血管病学进展,2020,(5):547.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.025]
　LIANG Keyan,YANG Fang,CHU Jingjie.Four-dimensional Echocardiography for Evaluation of Right Ventricular Systolic Function in Dilated Cardiomyopathy and Its Clinical Significance[J].Advances in Cardiovascular Diseases,2020,(6):547.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.025]
[4]宋元秀 崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,(2):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
　SONG Yuanxiu,CUI Ming.Correlation Between Mitochondrial Dynamics and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(6):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[5]唐毅 唐艺金 黄培 杨小燕 张翼 彭建强 郑昭芬 王银珍.人附睾蛋白4对扩张型心肌病患者短期预后评估的价值[J].心血管病学进展,2021,(11):1052.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]
　TANG Yi,TANG Yijin,HANG Pei,et al.The Value of Human Epididymal Protein 4 in Assessment of Short-Term Prognosis of Patients with Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(6):1052.[doi:10.16806/j.cnki.issn.1004-3934.2021.11.000]